Sentences with phrase «french drugmaker»

Consider that malaria affects more than 500 million people worldwide, and yet this past summer the Financial Times reported that French drugmaker Sanofi - Aventis faced half the demand it had expected for its anti-malaria compound artesunate.

Another promising drug for ALS is being developed by French drugmaker AB Science SA (ABS.PA), which in March reported positive late - stage data on its drug, masitinib.

Alnylam also said it would advance patisiran in the United States, Canada and Western Europe, while French drugmaker Sanofi would commercialize it in the rest of the world.

Alcaliber is majority - owned by Spanish billionaire Juan Abello's investment fund Torreal SA, with French drugmaker Sanofi also holding a 40 per cent stake.

PARIS (Reuters)- French drugmaker and healthcare group Sanofi is to buy privately - held U.S vaccines biotech company Protein Sciences for an initial amount of $ 650 million, as Sanofi steps up its acquisition program after recently missing two large deals.

The pattern repeated itself six months later when Lantus, from French drugmaker Sanofi, was marked up 11.9 percent, and Levemir, made by Novo Nordisk A / S, matched again exactly.

On Monday, French drugmaker Sanofi SA said it would buy U.S. - based hemophilia drugmaker Bioverativ Inc. for over $ 11.5 billion.

LONDON, April 16 - Shire, the London - listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $ 2.4 billion.

French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($ 4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.

The French drugmaker is nearing a deal to acquire biotechnology company Bioverativ for $ 105 a share.

PARIS / LONDON, Jan 29 (Reuters)- French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($ 4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.

Not exact matches

In the early hours of Monday morning, French drug giant Sanofi said it would buy hemophilia drugmaker Bioverativ, a Biogen spinout that is less than a year old, for $ 11.6 billion.

Swiss food group Nestle is to buy U.S. drugmaker Pfizer's infant nutrition business for $ 11.85 billion, beating out French rival Danone in the battle for dominance of baby food in fast - growing emerging markets.